rs575017579
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001369.3(DNAH5):c.5647C>T(p.Arg1883*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000124 in 1,613,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001369.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.5647C>T | p.Arg1883* | stop_gained | Exon 34 of 79 | 1 | NM_001369.3 | ENSP00000265104.4 | ||
DNAH5 | ENST00000681290.1 | c.5602C>T | p.Arg1868* | stop_gained | Exon 34 of 79 | ENSP00000505288.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251238Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135758
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461814Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727200
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74306
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 430011). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 19357118, 23891469, 25186273, 27618201). This variant is present in population databases (rs575017579, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg1883*) in the DNAH5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH5 are known to be pathogenic (PMID: 11788826, 16627867). -
- -
not provided Pathogenic:1
The R1883X variant in the DNAH5 gene has been reported previously in the homozygous state in an individual with PCD (Failly et al., 2009); it has also been observed in the heterozygous state without a second identifiable variant in an unrelated individual with PCD (Zariwala et al., 2013). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Numerous protein truncating variants downstream of R188X have been reported in the Human Gene Mutation Database in association with PCD (Stenson et al., 2014), supporting the pathogenicity of more upstream truncating variants. R1883X was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R1883X as a pathogenic variant. -
DNAH5-related disorder Pathogenic:1
The DNAH5 c.5647C>T variant is predicted to result in premature protein termination (p.Arg1883*). This variant has reported in individuals with primary ciliary dyskinesia (Failly et al 2009. PubMed ID: 19357118; Raidt J et al 2014. PubMed ID: 25186273). This variant is reported in 0.0050% of alleles in individuals of East Asian descent in gnomAD ). Nonsense variants in DNAH5 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at